+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Middle East & Africa Infertility (Testing and Treatment) Market 2019-2027

  • ID: 4774253
  • Report
  • Region: Africa, East Africa, Middle East
  • 103 pages
  • Triton Market Research
UP TO OFF
until Jan 31st 2020
1 of 4

FEATURED COMPANIES

  • Andrology Solutions
  • Esco Micro Pte. Ltd.
  • Genea
  • Irvine Scientific
  • Origio
  • Progyny
  • MORE
Market Outlook

This research envisions the market for infertility (testing and treatment) in the Middle East & Africa to witness a CAGR of 6.43% over the forecast period 2019-2027.

Saudi Arabia, Turkey, the UAE, South Africa and countries in rest of MEA have been considered for analysis in the report on the infertility (testing and treatment) market in the Middle East & Africa.

The increase in the initiatives undertaken by the government for the healthcare infrastructure development, growth in the lifestyle-related & gynecological disorders, declining pregnancy rates in women and a burgeoning population are some of the factors that contribute to the growth of the infertility (testing and treatment) market in the MEA region. Despite these factors, lack of awareness about advanced fertilization techniques, exorbitant costs required for IVF procedures, lack of skilled professionals in the field, shortage of advanced IVF methods and ethical concerns are reasons impeding the growth of the market in the Middle East & Africa region.

Microsurgical sperm aspiration (MESA) is one of the types of male infertility treatments. MESA is a surgical procedure that directly extracts sperm from the epididymis and uses it in the In Vitro Fertilization cycle. MESA is performed on individuals who suffer from a blockage in epididymis which results in no sperm ejaculation. This blockage might be due to a previous hernia or vasectomy. MESA does less damage to testis and epididymis and gives a better quality of specimen collection. A large number of sperms can be retrieved using this process and can be stored to be used in future cycles of ICSI. However, it is a very time-consuming and demanding process.

In men, social fear leads to low esteem and often makes the situation worse, resulting in erectile dysfunction and loss of desire. However, infertility is majorly due to low-quality semen or low sperm count. Historically female infertility has always been focused upon, and male’s problems have been circumvented and not addressed directly. Often men take infertility as an assault on their manhood. Such thought processes need to be done away as they act as a barrier to market growth.

Competitive Outlook

some of the biggest brands in the market are Endo Pharmaceuticals, The Cooper Companies, Inc., Progyny, Esco Micro Pte. Ltd., Quest Diagnostic, Halotech DNA, Ferring Pharmaceuticals, Genea, Vitrolife AB, Andrology Solutions, Thermo Fisher Scientific, Inc., Merck, OvaScience, Irvine Scientific and Origio.
Note: Product cover images may vary from those shown
2 of 4

FEATURED COMPANIES

  • Andrology Solutions
  • Esco Micro Pte. Ltd.
  • Genea
  • Irvine Scientific
  • Origio
  • Progyny
  • MORE
1. Infertility (Testing And Treatment) Market - Summary

2. Industry Outlook
2.1. Market Definition
2.2. Key Insights
2.2.1. Ivf Dominates the Female Treatment Market
2.2.2. Oxidative Stress Analysis is the Fastest Growing Male Infertility Testing Market
2.3. Porter’s Five Force Analysis
2.3.1. Threat of New Entrants
2.3.2. Threat of Substitute
2.3.3. Bargaining Power of Buyers
2.3.4. Bargaining Power of Suppliers
2.3.5. Intensity of Competitive Rivalry
2.4. Key Impact Analysis
2.4.1. Treatment Options
2.4.2. Quality of Medical Procedures
2.4.3. Price of Treatments
2.4.4. Shift Towards Medical Tourism
2.4.5. Reimbursement
2.5. Market Attractiveness Index
2.6. Vendor Scorecard
2.7. Industry Components
2.7.1. Raw Material Procurement
2.7.2. Manufacturing
2.7.3. Supply LoGIStics
2.7.4. Distribution Channels
2.7.5. End-Users
2.8. Regulatory Framework
2.9. Market Drivers
2.9.1. Rise in Infertility And Treatment Awareness
2.9.2. Medical Tourism in Fertility Treatments
2.9.3. Surrogacy Laws Are Getting More Defined
2.9.4. Healthcare Advances Have Fine-Tuned Fertility Treatment
2.9.5. Increasing Effectiveness of Treatments
2.9.6. Healthier Donor Eggs
2.9.7. Introduction of New Testing Devices
2.10. Market Restraints
2.10.1. Treatment Procedure Out of Reach For Many Due to High Costs
2.10.2. Country-Wise Regulatory Issues
2.11. Market Opportunities
2.11.1. Reducing the Cost of Treatment to Make It More Accessible
2.11.2. Ivf Attracting Investments From Private Equity Investors
2.11.3. Diy Testing Increasing Access And Reducing Cost
2.12. Market Challenges
2.12.1. Infertility Considered a Social Taboo Amongst Men
2.12.2. Perils of Multiple Pregnancies
2.12.3. Traditional Treatments Used Widely As An Alternative For Infertility Treatments

3. Infertility (Testing And Treatment) Market Outlook - By Gender
3.1. Male Gender
3.1.1. Testing
3.1.1.1. Dna Fragmentation
3.1.1.2. Oxidative Stress Analysis
3.1.1.3. Sperm Penetration Assay
3.1.1.4. Computer-Assisted Semen Analysis (Casa)
3.1.1.5. Sperm Agglutination
3.1.1.6. Microscopic Examination
3.1.1.7. Others
3.1.2. Treatment
3.1.2.1. Vasovasostomy And Vasoepididymostomy (Vasectomy Reversal)
3.1.2.2. Sperm Retrieval Treatment
3.1.2.3. Microsurgical Sperm Aspiration (Mesa)
3.1.2.4. Testicular Sperm Extraction (Tese)
3.1.2.5. Varicocele Repairs
3.1.2.6. Assisted Reproductive Techniques (Art)
3.1.2.7. Intrauterine Insemination (Iui)
3.1.2.8. In-Vitro Fertilization (Ivf)
3.1.2.9. Intracytoplasmic Sperm Injection (Icsi)
3.2. Female Gender
3.2.1. Female Infertility Testing
3.2.1.1. Ovulation Testing
3.2.1.2. Hysterosalpingography
3.2.1.3. Laparoscopy
3.2.1.4. Transvaginal Ultrasound
3.2.1.5. Ovarian Reserve Testing
3.2.1.6. Hormonal Level Testing
3.2.1.7. Others
3.2.2. Treatment
3.2.2.1. In-Vitro Fertilization
3.2.2.2. Intrauterine Insemination (Iui)
3.2.2.3. Drug And Hormone Therapies

4. Infertility (Testing And Treatment) Market Outlook - By End-Use
4.1. Fertility Clinics
4.2. Hospitals
4.3. Surgical Centers
4.4. Clinical Research Institutes

5. Infertility (Testing And Treatment) Market - Regional Outlook
5.1. Middle East & Africa
5.1.1. Country Analysis
5.1.1.1. United Arab Emirates
5.1.1.2. Turkey
5.1.1.3. Saudi Arabia
5.1.1.4. South Africa
5.1.1.5. Rest of Middle East & Africa

6. Competitive Landscape
6.1. Andrology Solutions
6.2. Endo Pharmaceuticals
6.3. Progyny
6.4. Ferring Pharmaceuticals
6.5. Genea
6.6. Halotech Dna
6.7. Irvine Scientific
6.8. Merck
6.9. Origio
6.10. Ovascience
6.11. Vitrolife Ab
6.12. Thermo Fisher Scientific, Inc.
6.13. the Cooper Companies, Inc.
6.14. Quest Diagnostic
6.15. Esco Micro Pte. Ltd.

7. Research Methodology & Scope
7.1. Research Scope & Deliverables
7.1.1. Objectives of Study
7.2. Sources of Data
7.2.1. Primary Data Sources
7.2.2. Secondary Data Sources
7.3. Research Methodology
7.3.1. Evaluation of Proposed Market
7.3.2. Identification of Data Sources
7.3.3. Assessment of Market Determinants
7.3.4. Data Collection
7.3.5. Data Validation & Analysis

List of Tables
Table 1: Middle East & Africa Infertility (Testing And Treatment) Market, By Country, 2019-2027 (In $ Million)
Table 2: Market Attractiveness Index
Table 3: Vendor Scorecard
Table 4: Regulatory Framework
Table 5: Average Cost Comparison of Infertility Treatments
Table 6: Middle East & Africa Infertility (Testing And Treatment) Market, By Gender, 2019-2027, (In $ Million)
Table 7: Middle East & Africa Infertility (Testing And Treatment) Market, By Male Gender, 2019-2027, (In $ Million)
Table 8: Middle East & Africa Infertility (Testing And Treatment) Market, By Male Infertility Testing, 2019-2027, (In $ Million)
Table 9: Pros And Cons of Dna Sharing Methods
Table 10: Middle East & Africa Infertility (Testing And Treatment) Market, By Female Gender, 2019-2027, (In $ Million)
Table 11: Middle East & Africa Infertility (Testing And Treatment) Market, By Female Infertility Testing, 2019-2027, (In $ Million)
Table 12: Cost of Ovulation Testing Kits in the Us
Table 13: Cost of Hormonal Test in the Us
Table 14: Average Cost of Some Infertility Treatments
Table 15: Some Common Drug Therapies
Table 16: Middle East & Africa Infertility (Testing And Treatment) Market, 2019-2027 (In $ Million)
Table 17: Middle East & Africa Infertility (Testing And Treatment) Market, By Gender, 2019-2027 (In $ Million)
Table 18: Middle East & Africa Infertility (Testing And Treatment) Market, By Male Gender, 2019-2027 (In $ Million)
Table 19: Middle East & Africa Infertility (Testing And Treatment) Market, By Male Infertility Testing, 2019-2027 (In $ Million)
Table 20: Middle East & Africa Infertility (Testing And Treatment) Market, By Female Gender, 2019-2027 (In $ Million)
Table 21: Middle East & Africa Infertility (Testing And Treatment) Market, By Female Infertility Testing, 2019-2027 (In $ Million)
Table 22: Middle East & Africa Infertility (Testing And Treatment) Market, By End-Use, 2019-2027 (In $ Million)

List of Figures
Figure 1: Middle East & Africa Infertility (Testing And Treatment) Market, By End-User, 2018 & 2027 (In %)
Figure 2: Porter’s Five Force Analysis
Figure 3: Key Buying Impact Analysis
Figure 4: Industry Components
Figure 5: Major Fertility Treatment Destination Ranking
Figure 6: Clinical Algorithm For the Evaluation of Infertile Woman
Figure 7: Rate of Multiple Deliveries
Figure 8: Middle East & Africa Infertility (Testing And Treatment) Market, By Male Gender, 2019-2027 (In $ Million)
Figure 9: Middle East & Africa Infertility (Testing And Treatment) Market, By Testing, 2019-2027 (In $ Million)
Figure 10: Middle East & Africa Infertility (Testing And Treatment) Market, By Dna Fragmentation, 2019-2027 (In $ Million)
Figure 11: Causes of Sperm Dna Fragmentation
Figure 12: Middle East & Africa Infertility (Testing And Treatment) Market, By Oxidative Stress Analysis, 2019-2027 (In $ Million)
Figure 13: Middle East & Africa Infertility (Testing And Treatment) Market, By Sperm Penetration Assay, 2019-2027 (In $ Million)
Figure 14: Middle East & Africa Infertility (Testing And Treatment) Market, By Computer-Assisted Semen Analysis, 2019-2027 (In $ Million)
Figure 15: Middle East & Africa Infertility (Testing And Treatment) Market, By Sperm Agglutination, 2019-2027 (In $ Million)
Figure 16: Middle East & Africa Infertility (Testing And Treatment) Market, By Microscopic Examination, 2019-2027 (In $ Million)
Figure 17: Middle East & Africa Infertility (Testing And Treatment) Market, By Others, 2019-2027 (In $ Million)
Figure 18: Middle East & Africa Infertility (Testing And Treatment) Market, By Treatment, 2019-2027 (In $ Million)
Figure 19: Middle East & Africa Infertility (Testing And Treatment) Market, By Female Gender, 2019-2027 (In $ Million)
Figure 20: Middle East & Africa Infertility (Testing And Treatment) Market, By Female Infertility Testing, 2019-2027 (In $ Million)
Figure 21: Middle East & Africa Infertility (Testing And Treatment) Market, By Ovulation Testing, 2019-2027 (In $ Million)
Figure 22: Middle East & Africa Infertility (Testing And Treatment) Market, By Hysterosalpingography, 2019-2027 (In $ Million)
Figure 23: Middle East & Africa Infertility (Testing And Treatment) Market, By Laparoscopy, 2019-2027 (In $ Million)
Figure 24: Middle East & Africa Infertility (Testing And Treatment) Market, By Transvaginal Ultrasound, 2019-2027 (In $ Million)
Figure 25: Middle East & Africa Infertility (Testing And Treatment) Market, By Ovarian Reserve Testing, 2019-2027 (In $ Million)
Figure 26: Middle East & Africa Infertility (Testing And Treatment) Market, By Hormonal Level Testing, 2019-2027 (In $ Million)
Figure 27: Middle East & Africa Infertility (Testing And Treatment) Market, By Others, 2019-2027 (In $ Million)
Figure 28: Middle East & Africa Infertility (Testing And Treatment) Market, By Female Infertility Treatment, 2019-2027 (In $ Million)
Figure 29: Middle East & Africa Infertility (Testing And Treatment) Market, By Fertility Clinics, 2019-2027 (In $ Million)
Figure 30: Middle East & Africa Infertility (Testing And Treatment) Market, By Hospitals, 2019-2027 (In $ Million)
Figure 31: Middle East & Africa Infertility (Testing And Treatment) Market, By Surgical Centers, 2019-2027 (In $ Million)
Figure 32: Middle East & Africa Infertility (Testing And Treatment) Market, By Clinical Research Institutes, 2019-2027 (In $ Million)
Figure 33: Middle East & Africa Infertility (Testing And Treatment) Market, Regional Outlook, 2018 & 2027 (In %)
Figure 34: United Arab Emirates Infertility (Testing And Treatment) Market, 2019-2027 (In $ Million)
Figure 35: Turkey Infertility (Testing And Treatment) Market, 2019-2027 (In $ Million)
Figure 36: Saudi Arabia Infertility (Testing And Treatment) Market, 2019-2027 (In $ Million)
Figure 37: South Africa Infertility (Testing And Treatment) Market, 2019-2027 (In $ Million)
Figure 38: Rest of Middle East & Africa Infertility (Testing And Treatment) Market, 2019-2027 (In $ Million)
Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4
  • Andrology Solutions
  • Endo Pharmaceuticals
  • Progyny
  • Ferring Pharmaceuticals
  • Genea
  • Halotech Dna
  • Irvine Scientific
  • Merck
  • Origio
  • Ovascience
  • Vitrolife AB
  • Thermo Fisher Scientific, Inc.
  • The Cooper Companies, Inc.
  • Quest Diagnostic
  • Esco Micro Pte. Ltd.
Note: Product cover images may vary from those shown
5 of 4

Loading
LOADING...

Adroll
adroll